Inventor
David J. Rawlings
Inventor
Seattle, WA, US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes33%
A61KPreparations for medical, dental or toiletry purposes25%
C07KPeptides25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%
PatentTitleYear
10,745,690Coupling endonucleases with end-processing enzymes drives high efficiency gene disruption202010,563,226Enhancing endonuclease based gene editing in primary cells202010,494,422CCR5 disruption of cells expressing anti-HIV chimeric antigen receptor (CAR) derived from broadly neutralizing antibodies20196,994,975'Expression and purification of ATM protein using vaccinia virus'20065,550,054'Hematopoietic restricted tyrosine kinase (BPK)'1996Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1996–2006Patents assigned to UNIV CALIFORNIA (2)· patent assignee history
1996Based in Santa Monica, CA, US· patent location history
2006–2020Based in Seattle, WA, US· patent location history
2019–2020Patents assigned to SEATTLE CHILDRENS HOSPITAL (2)· patent assignee history
2020Patents assigned to SEATTLE CHILDREN'S HOSPITAL (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SEATTLE CHILDRENS HOSPITAL | 2 | 2019–2020 |
| UNIV CALIFORNIA | 2 | 1996–2006 |
| SEATTLE CHILDREN'S HOSPITAL | 1 | 2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| Seattle, Washington, US | 4 | 2006–2020 |
| Santa Monica, California, US | 1 | 1996 |